Autonomix Medical (AMIX) Net Cash Flow (2023 - 2025)

Autonomix Medical (AMIX) has reported Net Cash Flow for 3 consecutive years, with $2.4 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Net Cash Flow fell 63.3% year-over-year to $2.4 million in Q4 2025; TTM through Dec 2025 was $1.3 million, a 87.99% decrease from a year earlier, with the FY2025 full-year figure at -$8.3 million, down 206.53% from the prior year.
• Net Cash Flow was $2.4 million for Q4 2025 at Autonomix Medical, up from -$1.1 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $7.7 million in Q1 2024 and troughed at -$1.9 million in Q2 2024.
• A 3-year average of $1.0 million and a median of -$269000.0 in 2023 frame the typical range for Net Cash Flow.
• The widest YoY moves for Net Cash Flow: up 85933.33% in 2024, down 193.61% in 2024.
• Over 3 years, Net Cash Flow stood at -$966000.0 in 2023, then soared by 790.27% to $6.7 million in 2024, then tumbled by 63.3% to $2.4 million in 2025.
• The last three Net Cash Flow figures came in at $2.4 million (Q4 2025), -$1.1 million (Q3 2025), and -$547000.0 (Q2 2025), per Business Quant data.